InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
3
T+90 hit rate
19%
T+90 mean return
-19.0%
Across 16 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Alland Leila, Directeur Médical. Director active across 2 companies, notably PMV Pharmaceuticals, Inc.. Cumulatively, 25 reports have been logged. Breakdown: 1 buy · 3 sells. Total volume traded: €114k. History available since 7 May 2021. The latest transaction was disclosed on 26 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations25 total
11,000 sharesCommon StockSEC:0001493152-26-031906:0
37,313 shares0Common StockSEC:0001493152-26-003803:0
36,101 shares0Common StockSEC:0001493152-25-004748:0
11,797 shares0Common StockSEC:0001493152-24-034048:0
23,611 shares0Common StockSEC:0001493152-24-026643:0
11,000 shares@ US$4.70914.7% of flowCommon StockSEC:0001493152-24-020542:0
Ideal exit: 10 Feb 2025 (T+270)
7,246 shares@ US$3.90149.7% of flowCommon StockSEC:0001493152-23-034854:0
6,291 shares@ US$6.6223.0% of flowCommon StockSEC:0001209191-23-049751:0
58,689 shares@ US$4.6277.0% of flowCommon StockSEC:0001493152-23-021651:0
13,400 shares0Common StockSEC:0001493152-22-027052:0
52,200 shares0Common StockSEC:0001209191-22-049692:0
100 shares@ US$3.900.2% of flowCommon StockSEC:0001209191-21-055438
100 shares@ US$3.900.0005% mcap0.3% of flowCommon StockSEC:0001209191-21-055438:0
3,900 shares@ US$3.900.019% mcap9.8% of flowCommon StockSEC:0001209191-21-055140:0
3,900 shares@ US$3.907.6% of flowCommon StockSEC:0001209191-21-055140
4,000 shares@ US$3.900.019% mcap10.2% of flowCommon StockSEC:0001209191-21-050670:0
4,000 shares@ US$3.907.8% of flowCommon StockSEC:0001209191-21-050670
4,000 shares@ US$3.900.019% mcap10.1% of flowCommon StockSEC:0001209191-21-045989:0
4,000 shares@ US$3.907.8% of flowCommon StockSEC:0001209191-21-045989
4,000 shares@ US$3.900.019% mcap9.8% of flowCommon StockSEC:0001209191-21-039035:0
4,000 shares@ US$3.907.5% of flowCommon StockSEC:0001209191-21-039035
77,181 shares0Common StockSEC:0001493152-21-013114:0
77,181 shares0Common StockSEC:0001493152-21-013114
4,000 shares@ US$3.909.9% of flowCommon StockSEC:0001209191-21-031300
4,000 shares@ US$3.900.019% mcap9.9% of flowCommon StockSEC:0001209191-21-031300:0
25 of 25 declarations
About Alland Leila
Alland Leila is the Chief Medical Officer and Board Member of PMV Pharmaceuticals, Inc. and ABEONA THERAPEUTICS INC. In these roles, she is responsible for medical strategy and product development, contributing to innovation in the biopharmaceutical sector.
